Dorex Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 20-12-2024
- Paid Up Capital ₹ 1.43 M
as on 20-12-2024
- Company Age 41 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.17 M
as on 20-12-2024
- Revenue -84.24%
(FY 2020)
- Profit -116.53%
(FY 2020)
- Ebitda -79.00%
(FY 2020)
- Net Worth -2.50%
(FY 2020)
- Total Assets -6.60%
(FY 2020)
About Dorex Pharmaceuticals (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.43 M.
The company currently has active open charges totaling ₹0.17 M.
Gaurav Verma and Sandeep Verma serve as directors at the Company.
- CIN/LLPIN
U24231HR1983PTC015949
- Company No.
015949
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jun 1983
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurugram, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dorex Pharmaceuticals (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Verma  | Director | 28-Aug-2006 | Current |
| Gaurav Verma | Director | 19-Apr-2004 | Current |
Financial Performance of Dorex Pharmaceuticals (India).
Dorex Pharmaceuticals (India) Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 84.24% decrease. The company also saw a substantial fall in profitability, with a 116.53% decrease in profit. The company's net worth dipped by a decrease of 2.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dorex Pharmaceuticals (India)?
In 2018, Dorex Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.17 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.02 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Jan 1984 | Bank Of India | ₹0.17 M | Open |
How Many Employees Work at Dorex Pharmaceuticals (India)?
Unlock and access historical data on people associated with Dorex Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dorex Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dorex Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
